Prognostic Value of Soluble ST2 (sST2) Serum Levels in Infants and Children with Heart Failure Complicating Congenital Heart Disease

Background Heart failure (HF) in infants and children with congenital heart disease (CHD) is a crucial complication with different outcomes. Many biomarkers are used as prognostic indicators. Soluble ST2 (sST2) is one of these markers studied in adults with HF. We aimed to study the prognostic value...

Full description

Bibliographic Details
Main Authors: Moustafa Abdel Raheem, Wael F Sedik
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2019-05-01
Series:International Journal of Pediatrics
Subjects:
Online Access:http://ijp.mums.ac.ir/article_12307_b64e4d030e1ac4df96f28a83d397aeba.pdf
id doaj-853d0acbdad44a0586944ae275c0af6f
record_format Article
spelling doaj-853d0acbdad44a0586944ae275c0af6f2020-11-25T00:15:12ZengMashhad University of Medical SciencesInternational Journal of Pediatrics2345-50472345-50552019-05-01759471948010.22038/ijp.2019.38305.329412307Prognostic Value of Soluble ST2 (sST2) Serum Levels in Infants and Children with Heart Failure Complicating Congenital Heart DiseaseMoustafa Abdel Raheem0Wael F Sedik1MD in Pediatrics, Assistant Professor of Pediatrics, Department of Pediatrics, Faculty of Medicine, Minia University, Minia City, Egypt.MD in Biochemistry, Lecturer in Biochemistry, Department of Biochemistry, Faculty of Medicine, Minia University, Minia City, Egypt.Background Heart failure (HF) in infants and children with congenital heart disease (CHD) is a crucial complication with different outcomes. Many biomarkers are used as prognostic indicators. Soluble ST2 (sST2) is one of these markers studied in adults with HF. We aimed to study the prognostic value of sST2 in CHD children with HF. Materials and Methods In current case-control study, thirty-six CHD infants and children with HF (20 males and 16 females) with mean age of 20.3±11.2 months were included in this study. Another 20 (12 males and 8 females) healthy children with mean age of 20.9±9.1 months served as controls. Clinical evaluation, echocardiography and sST2 levels assessment were done for all subjects. Results Our results showed that sST levels were significantly higher in diseased group than controls (30.85±2.48 ng/ml vs. 22.12±1.50ng/ml, respectively), and we recorded higher levels in more severely diseased children, according to Ross clinical classification and in those with poor prognosis than those with good prognosis. ROC curve for sST2 levels in diseased group showed that at cutoff point of more than 29.8 ng/ml, sensitivity of sST2 to predict poor prognosis of HF children was 95% with a specificity of 88%. Area under the curve (AUC) was 0.94. We found significant negative correlations between sST2 levels, and left ventricular ejection fraction (LVEF), and fractional shortening (LVFS), and significant positive correlations with heart rate (HR) respiratory rate (RR), cardio-thorathic (CT) ratio, left ventricular end diastolic, and systolic dimensions (LVEDd and  LVESd). Conclusion Increased sST2 levels in infants with CHD complicated with HF can be used as a good predictive indicator to unfavorable outcome in those patients.http://ijp.mums.ac.ir/article_12307_b64e4d030e1ac4df96f28a83d397aeba.pdfChildrenCongenital Heartheart failureSoluble ST2
collection DOAJ
language English
format Article
sources DOAJ
author Moustafa Abdel Raheem
Wael F Sedik
spellingShingle Moustafa Abdel Raheem
Wael F Sedik
Prognostic Value of Soluble ST2 (sST2) Serum Levels in Infants and Children with Heart Failure Complicating Congenital Heart Disease
International Journal of Pediatrics
Children
Congenital Heart
heart failure
Soluble ST2
author_facet Moustafa Abdel Raheem
Wael F Sedik
author_sort Moustafa Abdel Raheem
title Prognostic Value of Soluble ST2 (sST2) Serum Levels in Infants and Children with Heart Failure Complicating Congenital Heart Disease
title_short Prognostic Value of Soluble ST2 (sST2) Serum Levels in Infants and Children with Heart Failure Complicating Congenital Heart Disease
title_full Prognostic Value of Soluble ST2 (sST2) Serum Levels in Infants and Children with Heart Failure Complicating Congenital Heart Disease
title_fullStr Prognostic Value of Soluble ST2 (sST2) Serum Levels in Infants and Children with Heart Failure Complicating Congenital Heart Disease
title_full_unstemmed Prognostic Value of Soluble ST2 (sST2) Serum Levels in Infants and Children with Heart Failure Complicating Congenital Heart Disease
title_sort prognostic value of soluble st2 (sst2) serum levels in infants and children with heart failure complicating congenital heart disease
publisher Mashhad University of Medical Sciences
series International Journal of Pediatrics
issn 2345-5047
2345-5055
publishDate 2019-05-01
description Background Heart failure (HF) in infants and children with congenital heart disease (CHD) is a crucial complication with different outcomes. Many biomarkers are used as prognostic indicators. Soluble ST2 (sST2) is one of these markers studied in adults with HF. We aimed to study the prognostic value of sST2 in CHD children with HF. Materials and Methods In current case-control study, thirty-six CHD infants and children with HF (20 males and 16 females) with mean age of 20.3±11.2 months were included in this study. Another 20 (12 males and 8 females) healthy children with mean age of 20.9±9.1 months served as controls. Clinical evaluation, echocardiography and sST2 levels assessment were done for all subjects. Results Our results showed that sST levels were significantly higher in diseased group than controls (30.85±2.48 ng/ml vs. 22.12±1.50ng/ml, respectively), and we recorded higher levels in more severely diseased children, according to Ross clinical classification and in those with poor prognosis than those with good prognosis. ROC curve for sST2 levels in diseased group showed that at cutoff point of more than 29.8 ng/ml, sensitivity of sST2 to predict poor prognosis of HF children was 95% with a specificity of 88%. Area under the curve (AUC) was 0.94. We found significant negative correlations between sST2 levels, and left ventricular ejection fraction (LVEF), and fractional shortening (LVFS), and significant positive correlations with heart rate (HR) respiratory rate (RR), cardio-thorathic (CT) ratio, left ventricular end diastolic, and systolic dimensions (LVEDd and  LVESd). Conclusion Increased sST2 levels in infants with CHD complicated with HF can be used as a good predictive indicator to unfavorable outcome in those patients.
topic Children
Congenital Heart
heart failure
Soluble ST2
url http://ijp.mums.ac.ir/article_12307_b64e4d030e1ac4df96f28a83d397aeba.pdf
work_keys_str_mv AT moustafaabdelraheem prognosticvalueofsolublest2sst2serumlevelsininfantsandchildrenwithheartfailurecomplicatingcongenitalheartdisease
AT waelfsedik prognosticvalueofsolublest2sst2serumlevelsininfantsandchildrenwithheartfailurecomplicatingcongenitalheartdisease
_version_ 1725388192261079040